Rechargeable Pacemaker Technology in Deep Brain Stimulation: A Step Forward, But Not for Everyone

Area of Science:

• Neurosurgery
• Biomedical Engineering
• Neurology

Background:

• Rechargeable implantable pulse generators (IPGs) offer advantages and are standard in deep brain stimulation (DBS).
• Limited data exists on reasons for reverting to non-rechargeable systems.
• Understanding these transitions is crucial for optimizing patient care.

Observation:

• A cohort of 640 patients included 102 receiving rechargeable IPGs.
• Three patients required preemptive replacement with non-rechargeable IPGs.
• Reasons included handling/recharge issues, missed recharges causing severe symptoms, and twiddler's syndrome.

Findings:

• Despite widespread adoption, rechargeable IPG technology is not universally suitable.
• Specific patient-related factors and device management challenges can necessitate a switch to non-rechargeable IPGs.
• These instances highlight the need for personalized treatment approaches in DBS.

Implications:

• Clinical decision-making for IPG selection requires careful consideration of patient factors and potential challenges.
• Further research into patient-reported outcomes and device usability is warranted.
• This study underscores the importance of maintaining flexibility in neuromodulation therapy options.